Inclusion body myositis and myopathies. - Wikidata - wikimedia - TriplyDB

Inclusion body myositis and myopathies.

Inclusion body myositis and myopathies.

http://www.wikidata.org/entity/Q34289237

about

Interventions for dysphagia in long-term, progressive muscle disease Treatment for inclusion body myositis Treatment for inclusion body myositis Treatment for inclusion body myositis Treatment for inclusion body myositis How citation distortions create unfounded authority: analysis of a citation network Follistatin gene delivery enhances muscle growth and strength in nonhuman primates Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis Autoimmune Myopathies: Where Do We Stand?Idiopathic Inflammatory Myopathies: Clinical Approach and Management Emerging therapeutic options for sporadic inclusion body myositis Update in inclusion body myositis Incidence and prevalence of inflammatory myopathies: a systematic review Targeting protein homeostasis in sporadic inclusion body myositis.Hereditary inclusion body myopathy: a decade of progress Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.Diagnosis and classification of idiopathic inflammatory myopathies.Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.Immune and myodegenerative pathomechanisms in inclusion body myositis Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.Evaluation and construction of diagnostic criteria for inclusion body myositis Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice.Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.Mutation update for GNE gene variants associated with GNE myopathy.Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1.Ongoing developments in sporadic inclusion body myositis A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.Sporadic inclusion body myositis: new insights and potential therapy.Immunotherapy of inflammatory myopathies: practical approach and future prospects.An overview of polymyositis and dermatomyositis.Th1 response and systemic treg deficiency in inclusion body myositis.Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.

P2860

Q24186156-BEB1B3BD-303C-40A9-8944-8C51DC3F45AD Q24186948-BA54B9F9-CCDE-479C-88FC-D2C6FD122FC6 Q24192953-E4F9509F-0037-4403-8D2F-6F4BFDB8D781 Q24197747-A0B67D25-1B8C-462D-8033-981A0975C4D8 Q24243648-E2C72D44-9BFC-40BA-8115-894279FDE001 Q24260685-596A9733-1D94-4DC5-A78E-6CD1B09E7AE7 Q24598350-9E0A1B86-2A19-498B-A5E0-9307BF99134A Q24642141-D90B165F-03B9-41D2-B240-1864EBB8FA1F Q26744554-D7688F13-09BC-4563-A344-E9081814EB3A Q26744705-03BF2733-3733-49EE-AC26-B8266E128488 Q26786571-B8754A69-635B-49D8-95EF-CA8976A81866 Q26829906-6606308B-1CC7-4339-BDBC-DB4BE98CE1C9 Q26999366-36A5D4EC-290F-4A42-96EF-1ACF68D87690 Q27324564-C1879632-B23C-4580-A949-2905DBE86986 Q28251720-47391ACB-D432-48FB-A33A-BD9998D4B34A Q28305085-7725CFC5-0669-4F27-A1FB-C4B387444C59 Q30245016-1618EE2B-993D-4853-B217-7C0B8CE81DE4 Q30249522-71C42BFD-5DAA-48A1-90D0-0DDD28D4D117 Q33270749-093B8DDD-34B4-497C-BF94-A6C6AAE86A6B Q33569443-BB31B50A-928E-42A9-8DEE-A7D8D7DBB8EF Q33753870-AE7DB0F0-F476-4772-ADC5-CB020C17FBF9 Q33784450-0749A158-6E58-47E6-AEC8-8CA323EE085B Q33806912-9AA3FF12-A631-418D-A07B-355421230679 Q33844947-085862EF-A9A1-47B2-ACDD-1BB8780BAD87 Q33869281-55956774-1B8A-4D09-93C3-062A2DC777DC Q34043780-4F3E27FB-412F-4230-9652-F90B1E7B76DB Q34130746-D69314A0-65E5-47AC-AE8F-73C721D916C3 Q34160071-DBBEF980-1255-450D-93FE-1D54B2573529 Q34167791-960C1E93-29C9-41D4-9910-9A18C08E63F3 Q34231117-D734D6E9-5B4A-4AD9-9FE2-278C5D0E3619 Q34389612-F6858555-D5DD-4151-B1FB-A3B3AAED3041 Q34519540-37D25E14-D674-486A-A65C-1D94E46856EA Q34520109-CE7179F6-C360-403A-AD4A-A0126CAC9829 Q34528042-9310606A-E261-4913-A723-FC150A9108BB Q34591787-65FAAD38-17DB-410A-9BC2-76C6CA7F9DF9 Q34627294-630542D0-58CB-4AD0-8A3D-40A798EF926E Q34667765-93286D93-5B1B-4970-9433-DD01955A362B Q35110718-F2C5879C-40EE-4696-B3AB-DA067AFE29E3 Q35163067-51219E30-E6AD-4045-B670-D03079A2D30C Q35213944-DC8EE861-F76B-45A8-A59A-2920DEF63847

P2860

Inclusion body myositis and myopathies.

http://www.wikidata.org/entity/Q34289237

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Inclusion body myositis and myopathies.

@ast

Inclusion body myositis and myopathies.

@en

Inclusion body myositis and myopathies.

@nl

type

label

Inclusion body myositis and myopathies.

@ast

Inclusion body myositis and myopathies.

@en

Inclusion body myositis and myopathies.

@nl

prefLabel

Inclusion body myositis and myopathies.

@ast

Inclusion body myositis and myopathies.

@en

Inclusion body myositis and myopathies.

@nl

P1433

Q34289237-504E05A3-14F8-446B-AD76-0C9AFC237963

P1476

Q34289237-443F3CA0-07E6-4C74-BA2E-A52801CCC4C6

P2093

Q34289237-137BFB88-A417-4974-8C3B-4A373D7A5255

Q34289237-42070839-5FC3-4A13-98E4-117F90E01702

Q34289237-94D5C367-00FC-403E-96C2-A022DDE47AC5

Q34289237-A3CA6997-2606-48A8-9469-800FE68DDBB1

Q34289237-AC492153-CDF2-4565-A813-710C4A702DBF

Q34289237-C39425A4-2703-4839-B401-7D9A1B511E44

Q34289237-F6C471CE-1F93-41D1-8544-0A396DF6EA6C

P2860

Q34289237-3ED059E8-4D16-414F-9BBA-14C247E23D63

Q34289237-533AC542-E0C7-406B-BA71-F7255ADAA2EF

Q34289237-6B5E6149-9579-4B46-9CE4-3416AE90B513

Q34289237-74620DCF-BFE3-4E49-A426-3F112F8E2E67

Q34289237-883DC5B3-F439-42AB-9397-964432618C75

Q34289237-8CAA7169-7E84-4341-A09C-29178C9AD108

P304

Q34289237-74E84007-0BA1-4011-9C91-CC4B95C1A250

P31

Q34289237-220F7FC8-A3DD-4A26-85C2-20CE83A53534

P356

Q34289237-23F76F9A-F25E-4E84-B44F-09E9E4022669

P433

Q34289237-D5437024-B67A-45DF-BB6F-90AFAF2CE9C9

P478

Q34289237-F4D70897-D997-47AC-8568-9A620B752580

P577

Q34289237-039C5628-BD52-40B4-870B-F68008FEE03F

P698

Q34289237-6670AD11-95DE-4153-A698-9ABC2FBCA96C

P356

P1433

Annals of Neurology

P1476

Inclusion body myositis and myopathies.

@en

P2093

Askanas V

http://www.w3.org/2001/XMLSchema#string

DiMauro S

http://www.w3.org/2001/XMLSchema#string

Engel A

http://www.w3.org/2001/XMLSchema#string

Griggs RC

http://www.w3.org/2001/XMLSchema#string

Karpati G

http://www.w3.org/2001/XMLSchema#string

Mendell JR

http://www.w3.org/2001/XMLSchema#string

Rowland LP

http://www.w3.org/2001/XMLSchema#string

P2860

Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy.

Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.

Inclusion body myositis: explanation for poor response to immunosuppressive therapy.

Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique.

Inclusion body myositis. A corticosteroid-resistant idiopathic inflammatory myopathy.

Inclusion body myositis: treatment with intravenous immunoglobulin.

P304

705-713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.410380504

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7486861

http://www.w3.org/2001/XMLSchema#string